Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Droz

Showing results (221-230 of 364) with videos related to

Pageof 37
Sort By:
Journal D'Urologie|January 1, 1980
[Therapeutic trials in inoperable carcinoma of the bladder (author's transl)]J P Droz, F Ben Ayed, B Pascal, et al.
Gynecologic Oncology|September 1, 1995
Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave RoussyS Culine, C Lhomme, J Kattan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Cisplatin-based chemotherapy in advanced seminoma: the Institut Gustave Roussy experienceS Culine, L Abs, M J Terrier-Lacombe, et al.
Bulletin Du Cancer|April 1, 1994
[Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases]Y Chraibi, S Culine, M J Terrier-Lacombe, et al.
British Journal of Cancer|March 1, 1995
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU GroupS D Fosså, J P Droz, G Stoter, et al.
Annales De Chirurgie|July 11, 2006
[Anaplastic thyroid carcinoma: aggressive radical resection and cervical reconstruction. A case report]A-C Collin, K Chekaroua, T Delaporte, et al.
Cancer|March 15, 1996
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experienceF Farhat, S Culine, C Théodore, et al.
Lancet (London, England)|May 22, 1993
Free hCG-beta subunit as tumour marker in urothelial cancerI Marcillac, P Cottu, C Théodore, et al.
Journal D'Urologie|January 1, 1982
[Cerebral metastases of malignant germinal tumors of the testis]M Brin, J P Droz, J M Caillaud, et al.
Cancer Detection and Prevention|November 23, 2001
Somatostatin receptor expression profile as a potential criterion for discrimination between seminoma and non-seminoma testicular tumorsN Baou, M Bouras, J P Droz, et al.
Pageof 37

Showing results (221-230 of 364) with videos related to

Sort By:
Pageof 37
Journal D'Urologie|January 1, 1980
[Therapeutic trials in inoperable carcinoma of the bladder (author's transl)]J P Droz, F Ben Ayed, B Pascal, et al.
Gynecologic Oncology|September 1, 1995
Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave RoussyS Culine, C Lhomme, J Kattan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Cisplatin-based chemotherapy in advanced seminoma: the Institut Gustave Roussy experienceS Culine, L Abs, M J Terrier-Lacombe, et al.
Bulletin Du Cancer|April 1, 1994
[Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases]Y Chraibi, S Culine, M J Terrier-Lacombe, et al.
British Journal of Cancer|March 1, 1995
Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU GroupS D Fosså, J P Droz, G Stoter, et al.
Annales De Chirurgie|July 11, 2006
[Anaplastic thyroid carcinoma: aggressive radical resection and cervical reconstruction. A case report]A-C Collin, K Chekaroua, T Delaporte, et al.
Cancer|March 15, 1996
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experienceF Farhat, S Culine, C Théodore, et al.
Lancet (London, England)|May 22, 1993
Free hCG-beta subunit as tumour marker in urothelial cancerI Marcillac, P Cottu, C Théodore, et al.
Journal D'Urologie|January 1, 1982
[Cerebral metastases of malignant germinal tumors of the testis]M Brin, J P Droz, J M Caillaud, et al.
Cancer Detection and Prevention|November 23, 2001
Somatostatin receptor expression profile as a potential criterion for discrimination between seminoma and non-seminoma testicular tumorsN Baou, M Bouras, J P Droz, et al.
Pageof 37